CA2054870A1 - Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives - Google Patents

Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives

Info

Publication number
CA2054870A1
CA2054870A1 CA2054870A CA2054870A CA2054870A1 CA 2054870 A1 CA2054870 A1 CA 2054870A1 CA 2054870 A CA2054870 A CA 2054870A CA 2054870 A CA2054870 A CA 2054870A CA 2054870 A1 CA2054870 A1 CA 2054870A1
Authority
CA
Canada
Prior art keywords
phosphonomethoxy
pyrimidine derivatives
antiviral
purine
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2054870A
Other languages
French (fr)
Other versions
CA2054870C (en
Inventor
Choung Un Kim
John C. Martin
Bing Yu Luh
Peter F. Misco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting Rega VZW
Institute of Organic Chemistry and Biochemistry CAS
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CA2054870A1 publication Critical patent/CA2054870A1/en
Application granted granted Critical
Publication of CA2054870C publication Critical patent/CA2054870C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3

Abstract

The present invention concerns nucleotide analogs and their compositions and use. In particular it relates to novel (phosphonomethoxy) methoxy purine/pyrimidine derivatives.
CA002054870A 1990-11-29 1991-11-04 Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives Expired - Lifetime CA2054870C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US619,856 1990-11-29
US07/619,856 US5208221A (en) 1990-11-29 1990-11-29 Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives

Publications (2)

Publication Number Publication Date
CA2054870A1 true CA2054870A1 (en) 1992-05-30
CA2054870C CA2054870C (en) 1995-08-29

Family

ID=24483605

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002054870A Expired - Lifetime CA2054870C (en) 1990-11-29 1991-11-04 Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives

Country Status (8)

Country Link
US (2) US5208221A (en)
EP (1) EP0494370B1 (en)
JP (1) JP3172803B2 (en)
AT (1) ATE124412T1 (en)
CA (1) CA2054870C (en)
DE (1) DE69110854T2 (en)
DK (1) DK0494370T3 (en)
ES (1) ES2074637T3 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208221A (en) * 1990-11-29 1993-05-04 Bristol-Myers Squibb Company Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
KR100386685B1 (en) * 1993-09-17 2003-12-31 길리애드 사이언시즈, 인코포레이티드 Nucleotide Homolog
US5502177A (en) * 1993-09-17 1996-03-26 Gilead Sciences, Inc. Pyrimidine derivatives for labeled binding partners
US5798340A (en) * 1993-09-17 1998-08-25 Gilead Sciences, Inc. Nucleotide analogs
US5656745A (en) * 1993-09-17 1997-08-12 Gilead Sciences, Inc. Nucleotide analogs
US5977061A (en) * 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use
US5969135A (en) * 1995-11-02 1999-10-19 Icn Pharmaceuticals, Inc. Oligonucleotide analogs with an amino acid or a modified amino alcohol residue
US6093816A (en) 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
US5922695A (en) * 1996-07-26 1999-07-13 Gilead Sciences, Inc. Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
US6765019B1 (en) 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
JP2003519232A (en) * 2000-01-07 2003-06-17 ウニフェルジテーレ・インステリング・アントウェルペン Purine derivatives, their production and their use
CN1291994C (en) 2000-07-21 2006-12-27 吉里德科学公司 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
KR100891366B1 (en) 2001-06-29 2009-04-02 인스티튜트 오브 오르가닉 케미스트리 앤드 바이오케미스트리, 어케더미 오브 사이언시스 오브 더 체크 리퍼블릭 6-?2-phosphonomethoxyalkoxy pyrimidine derivatives having antiviral activity
US20040023928A1 (en) * 2001-10-31 2004-02-05 Colacino Joseph Matthew Phosphonate nucleotide and thiadiazole compounds for the treatment of smallpox
US7247621B2 (en) * 2002-04-30 2007-07-24 Valeant Research & Development Antiviral phosphonate compounds and methods therefor
EP1583542B9 (en) * 2003-01-14 2008-10-22 Gilead Sciences, Inc. Compositions and methods for combination antiviral therapy
ATE496056T1 (en) * 2003-06-16 2011-02-15 Acad Of Science Czech Republic PYRIMIDINE COMPOUNDS WITH PHOSPHONATE GROUPS AS ANTIVIRAL NUCLEOTIDE ANALOGS
TWI471145B (en) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc Unitary pharmaceutical dosage form
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
WO2007014352A2 (en) * 2005-07-27 2007-02-01 Gilead Sciences, Inc. Antiviral phosphonate conjugates for inhibition of hiv
TWI444384B (en) 2008-02-20 2014-07-11 Gilead Sciences Inc Nucleotide analogues and their use in the treatment of malignancies
CN114588161A (en) * 2020-12-07 2022-06-07 四川大学华西医院 Hypoxanthine derivative with effect of preventing and treating pneumonia

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868187A (en) * 1980-09-16 1989-09-19 Syntex (U.S.A.) Inc. Anti-viral N-substituted pyrimidines
EP0116038B1 (en) * 1982-08-06 1987-12-16 Engineering Industries, Inc. Emulsion package and method of mixing the emulsion
CS233665B1 (en) * 1983-01-06 1985-03-14 Antonin Holy Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
CS263951B1 (en) * 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
US4850010A (en) * 1985-11-25 1989-07-18 Alcatel N.V. Telemetry terminal
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
NZ222553A (en) * 1986-11-18 1991-07-26 Bristol Myers Co Phosphonomethoxyalkylene purine and pyrimidine derivatives and pharmaceutical compositions
DE3790883T1 (en) * 1987-01-20 1988-12-08
DE3721959A1 (en) * 1987-07-03 1989-01-19 Mannesmann Kienzle Gmbh SENSOR FOR THE OPERATING CONDITION OF BRAKES
ATE113601T1 (en) * 1987-11-30 1994-11-15 Beecham Group Plc LINKS.
EP0338168A1 (en) * 1988-04-19 1989-10-25 Merrell Dow Pharmaceuticals Inc. Phosphonoalkylpurine derivatives
SE8801729D0 (en) * 1988-05-06 1988-05-06 Astra Ab PURINE DERIVATIVES FOR USE IN THERAPY
US4952707A (en) * 1988-06-30 1990-08-28 Tropix, Inc. Enzymatically-cleavable chemiluminescent fused polycyclic ring-containing 1,2-dioxetanes
EP0353955A3 (en) * 1988-08-02 1991-08-14 Beecham Group Plc Novel compounds
GB8907173D0 (en) * 1989-03-30 1989-05-10 Beecham Group Plc Novel compounds
US4988703A (en) * 1989-05-22 1991-01-29 Abbott Laboratories Carbocyclic nucleoside analogs with antiviral activity
GB8912043D0 (en) * 1989-05-25 1989-07-12 Beecham Group Plc Novel compounds
US5208221A (en) * 1990-11-29 1993-05-04 Bristol-Myers Squibb Company Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives

Also Published As

Publication number Publication date
ES2074637T3 (en) 1995-09-16
JP3172803B2 (en) 2001-06-04
JPH04266893A (en) 1992-09-22
ATE124412T1 (en) 1995-07-15
US5208221A (en) 1993-05-04
EP0494370A1 (en) 1992-07-15
US5386030A (en) 1995-01-31
DE69110854T2 (en) 1995-12-07
DE69110854D1 (en) 1995-08-03
CA2054870C (en) 1995-08-29
DK0494370T3 (en) 1995-08-28
EP0494370B1 (en) 1995-06-28

Similar Documents

Publication Publication Date Title
CA2054870A1 (en) Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
MY102025A (en) Improvements in or relating to novel difluoro antiviral agents
IL89796A0 (en) Bis-(hydroxymethyl)cyclobutyl purine and pyrimidine derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
AU1261488A (en) Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
IL98702A (en) 9-purinyl phosphonic acid derivatives their preparation and pharmaceutical compositions containing them
AU7855191A (en) 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents
EP0409227A3 (en) Pyrimidine and purine nucleosides, their preparation and use as medicaments
EP0515107A3 (en) Azolo (1,3,5) triazines as adenosine antagonists
GB9218810D0 (en) Antiviral pyrimidine nucleosides
ZA901993B (en) Antiviral compositions
AP9000166A0 (en) Antiviral tetrahydroimidazol(1.4)benzodiazepin-2-thiones
AU633065B2 (en) 3'-substituted methyl nucleosides as antiviral agents
FI944933A (en) 7-Disubstituted methyl-4-oxo-3H, 5H-pyrrolo (3,2-d) pyrimidine and pharmaceutical uses and compositions containing it
NZ232013A (en) Substituted pyrido(2,3-d)pyrimidines and pharmaceutical compositions
EP0515108A3 (en) Azolo (1,3,5) triazines as adenosine antagonists
GB9116030D0 (en) Antiviral compositions
IL88854A (en) Pyrimidine and purine 1,2-butadiene-4-ol derivatives and pharmaceutical compositions containing the same
AU1699992A (en) Dibenzothiazepinthione as antiviral agents
IL93001A0 (en) Purine nucleosides and nucleotides,processes for the preparation thereof and pharmaceutical compositions containing the same
CY1655A (en) Antiviral composition comprising isopropyldeoxyuridine
GB9506644D0 (en) Preparation of nucleoside analogues
EP0477871A3 (en) Antiviral composition, containing guanine derivatives
GB8826371D0 (en) Antiviral compositions
GB9111967D0 (en) 2,5'-nucleotide analogs as antiviral agents
IE871382L (en) Antiviral compositions.

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry